ElenaSRatnerMD
Obstetrics & Gynecology • New Haven, CTGynecologic Oncology
Associate Professor, co-Division Director, Gynecologic Oncology,Yale University School of Medicine
Dr. Ratner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave
Yale Physicians Bldg 3RD FLR
New Haven, CT 06519Phone+1 203-785-4176Fax+1 203-785-5886
Summary
- Dr. Elena Ratner is an obstetrician/gynecologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Yale-New Haven Hospital and Lawrence + Memorial Hospital. She received her medical degree from University at Buffalo, School of Medicine and Biomedical Sciences and has been in practice 14 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology and gynecologic oncology.
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2007 - 2010- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 2003 - 2007
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
CT State Medical License 2007 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- 4 citationsBenefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy.Jessie Y. Li, Johanna D'Addario, Joan Tymon-Rosario, Gulden Menderes, Melissa R. Young
American Journal of Clinical Oncology. 2021-04-01 - 243 citationsLandscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.Siming Zhao, Murim Choi, John D. Overton, Stefania Bellone, Dana M. Roque
Proceedings of the National Academy of Sciences of the United States of America. 2013-02-19 - 127 citationsRandomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas ...Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Clinical Cancer Research. 2020-08-01
Journal Articles
- Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
Press Mentions
In Memoriam: Peter E. Schwartz, MDOctober 21st, 2024- 2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023
- Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
